“…Therefore, quantitative detection of fPSA and PSA–ACT can effectively help diagnose prostate cancer. However, the low cutoff limit of the PSA (2.5–4 ng/mL) challenges current detection methods. , Techniques such as surface plasmon resonance (SPR), quartz crystal microbalance (QCM), electrochemical signal transduction, and microcantilever have all been explored for the detection of PSAs. , Many approaches including self-assembled monolayers (SAM), biotinylation, fluorescent labeling, protein linkers or ligands, nanoparticle conjugates, and secondary antibodies have been developed to improve detection sensitivity. ,,− Among these different approaches, however, label-free detection methods are of interest for future biosensor applications. , We have recently demonstrated that neutron reflection (NR) is one of the techniques that can effectively determine antibody molecular orientations at the solid/water interfaces. ,, In this paper, spectroscopic ellipsometry (SE), NR, and dual polarization interferometry (DPI) have been combined to investigate the interfacial assembly of PSA antibody [mouse monoclonal anti-human prostate-specific antigen (anti-hPSA)] at the silicon oxide/water interface and the subsequent in situ antigen binding. The direct determination of in situ interfacial antibody orientation and its relationship to antigen binding is an important step in optimizing biosensor efficiency.…”